Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Pioneering use of CRISPR for upregulation of utrophin
Ground-breaking work underway using CRISPR
Using ExAC to reassess the pathogenicity of Mendelian disease genes in cardiomyopathy
ExAC used to reassess pathogenicity of Mendelian disease
Canada’s first cardiac precision medicine program
Deciphering the genetic code of pediatric heart disease